Victoria K. Welsh

Sep 12, 2024 | laytons.com | Victoria K. Welsh

As international travel evolves into a new era, we will be explaining the UK’s new Electronic Travel Authorisation (ETA), the EU’s forthcoming European Travel Information and Authorisation System (ETIAS) and discussing the USA’s ESTA updates and common pitfalls. Attendees can expect an informative and interactive session providing valuable updates to facilitate smoother international travel in this digital world.

Dec 19, 2023 | glaisyers.com | Victoria K. Welsh

The Government recently announced several expansions to the Youth Mobility visa category, effective from 31 January 2024, pursuant to trade agreements the UK has signed worldwide: For Australians and Canadians, the age limit for the Youth Mobility visa is raised to 35 years of age, with a three-year validity on the visa if approved. Those nationals already in the UK can extend their existing two-year visa for an additional year.

Nov 24, 2023 | glaisyers.com | Victoria K. Welsh

Following the Nationality and Borders Act 2022 receiving Royal Assent, the Home Office has introduced the Electronic Travel Authorisation (“ETA”) scheme which was provided for in the Act. This is a new requirement for non-visa nationals travelling to the UK, who must apply for and be granted an ETA before travelling. This is in line with the USA’s ESTA program and the forthcoming ETIAS for the European Union from mid-2025, as well as other similar systems around the world.

Nov 22, 2023 | laytons.com | Victoria K. Welsh

In the September Statement of Changes, the Youth Mobility visa category was expanded for Australian, Canadian, and Andorran nationals, effective from 31 January 2024, pursuant to trade agreements the UK has recently signed with those countries: For Australians and Canadians, the age limit for the Youth Mobility visa is raised to 35 years of age, with a three-year validity on the visa if approved. Those nationals already in the UK can extend their existing two-year visa for an additional year.

Oct 26, 2023 | bjgp.org | Victoria K. Welsh |Kayleigh J. Mason |James Bailey |Ram Bajpai

analgesia COVID-19 pandemic drug prescribing musculoskeletal diseases musculoskeletal pain primary care INTRODUCTION Rheumatic and musculoskeletal diseases (RMDs), defined as problems of the joints, muscles, and bones,1 cause a high disease burden globally.2 In the UK, primary care is generally the first point of care for adults and children with RMDs, with 20% of adults consulting for an RMD annually.3 A multidisciplinary approach to management is recommended including advice, self- care,...